Telmisartan tablets represent a generic version of Boehringer Ingelheim Pharmaceuticals’ Micardis tablets.
As of June 30, India-based Jubilant holds 70 drug applications filed through the FDA, 44 of which have been approved.
More articles on supply chain:
Medical device, drug recalls soar in Q2
AMA urges Mylan to lower cost of EpiPens
Mylan vows to reduce patient costs in light of EpiPen pricing scandal
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.